143 related articles for article (PubMed ID: 25939167)
1. The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.
Hanafin NM; Persons KS; Holick MF
In Vitro Cell Dev Biol Anim; 1994 Mar; 30A(3):187-91. PubMed ID: 25939167
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
3. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1,25 dihydroxyvitamin D3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes.
Sebag M; Gulliver W; Kremer R
J Invest Dermatol; 1994 Sep; 103(3):323-9. PubMed ID: 8077697
[TBL] [Abstract][Full Text] [Related]
5. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
Ratnam AV; Bikle DD; Su MJ; Pillai S
J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium.
Matsumoto K; Hashimoto K; Nishida Y; Hashiro M; Yoshikawa K
Biochem Biophys Res Commun; 1990 Jan; 166(2):916-23. PubMed ID: 2405860
[TBL] [Abstract][Full Text] [Related]
7. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes.
Ratnam AV; Bikle DD; Cho JK
J Cell Physiol; 1999 Feb; 178(2):188-96. PubMed ID: 10048583
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
10. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.
Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K
J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504
[TBL] [Abstract][Full Text] [Related]
11. Relative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression.
Sebag M; Henderson J; Rhim J; Kremer R
J Biol Chem; 1992 Jun; 267(17):12162-7. PubMed ID: 1318311
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
13. Increased PKC activity in cultured human keratinocytes and fibroblasts after treatment with 1 alpha, 25-dihydroxyvitamin D3.
Hanafin NM; Persons KS; Holick MF
J Cell Biochem; 1995 Feb; 57(2):362-70. PubMed ID: 7759571
[TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
Itin PH; Pittelkow MR; Kumar R
Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
[TBL] [Abstract][Full Text] [Related]
16. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.
Hulla W; Kállay E; Krugluger W; Peterlik M; Cross HS
Int J Cancer; 1995 Sep; 62(6):711-6. PubMed ID: 7558419
[TBL] [Abstract][Full Text] [Related]
17. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium.
Su MJ; Bikle DD; Mancianti ML; Pillai S
J Biol Chem; 1994 May; 269(20):14723-9. PubMed ID: 7910167
[TBL] [Abstract][Full Text] [Related]
19. Time-course study of 1,25-(OH)2-vitamin D3 induction of homologous receptor and c-myc in nontransformed and transformed C3H/10T1/2 cell clones.
Paatero GI; Trydal T; Karlstedt KA; Aarskog D; Lillehaug JR
Int J Biochem; 1994 Mar; 26(3):367-74. PubMed ID: 8187933
[TBL] [Abstract][Full Text] [Related]
20. The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes.
Chen TC; Persons K; Liu WW; Chen ML; Holick MF
J Invest Dermatol; 1995 Jan; 104(1):113-7. PubMed ID: 7798628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
